Request Demo
Last update 25 Feb 2026
Enterovirus type 71 vaccine(Beijing Luzhu Biopharmaceutical)
Last update 25 Feb 2026
Overview
Basic Info
Drug Type Inactivated vaccine, Prophylactic vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Enterovirus type 71 vaccine(Beijing Luzhu Biopharmaceutical)NCT05913024
A Single-center, Randomized, Blinded, Different Doses, Positive Control, Phase II to Evaluate the Inactivated EV71 Vaccine Immunogenicity and Safety in Healthy Volunteers Aged 6 to 71 Months
CTR20201179
单中心、随机、双盲、不同剂量、安慰剂对照评价6月龄-49岁健康人群应用肠道病毒71型灭活疫苗安全性与耐受性
[Translation] A single-center, randomized, double-blind, different-dose, placebo-controlled study to evaluate the safety and tolerability of inactivated enterovirus 71 vaccine in healthy people aged 6 months to 49 years
100 Clinical Results associated with Enterovirus type 71 vaccine(Beijing Luzhu Biopharmaceutical)
Login to view more data
100 Translational Medicine associated with Enterovirus type 71 vaccine(Beijing Luzhu Biopharmaceutical)
Login to view more data
100 Patents (Medical) associated with Enterovirus type 71 vaccine(Beijing Luzhu Biopharmaceutical)
Login to view more data
1
Literatures (Medical) associated with Enterovirus type 71 vaccine(Beijing Luzhu Biopharmaceutical)01 Jun 2014Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
[Discussion on the vaccination strategy of enterovirus type 71 vaccine].
Article
Author: Tan, Xiaojuan ; Xu, Wenbo
100 Deals associated with Enterovirus type 71 vaccine(Beijing Luzhu Biopharmaceutical)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Enterovirus 71 infection | Phase 2 | China | 19 Oct 2021 | |
| Enterovirus 71 infection | Phase 2 | China | 19 Oct 2021 | |
| Hand, Foot and Mouth Disease | Phase 2 | China | 19 Oct 2021 | |
| Hand, Foot and Mouth Disease | Phase 2 | China | 19 Oct 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free